Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
242
-
Total 13F shares, excl. options
-
61,078,573
-
Shares change
-
+2,992,903
-
Total reported value, excl. options
-
$6,058,905,131
-
Value change
-
+$247,459,592
-
Put/Call ratio
-
52.6%
-
Number of buys
-
127
-
Number of sells
-
-150
-
Price
-
$99.20
Significant Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q4 2018
350 filings reported holding BLUE - BLUEBIRD BIO INC - COM as of Q4 2018.
BLUEBIRD BIO INC - COM (BLUE) has 242 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61,078,573 shares
.
Largest 10 shareholders include FMR LLC (8,204,161 shares), WELLINGTON MANAGEMENT GROUP LLP (7,391,828 shares), Capital Research Global Investors (6,699,431 shares), Capital International Investors (5,050,758 shares), Vanguard Group Inc (4,796,557 shares), BAILLIE GIFFORD & CO (4,529,123 shares), Capital World Investors (3,712,781 shares), BlackRock Inc. (2,986,142 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,271,545 shares), and STATE STREET CORP (1,159,886 shares).
This table shows the top 242 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.